Search bioRxiv⌕ Search

Biology subjects

Scarcella, D.

Publications and source records attributed to Scarcella, D..

3 recordsLinked to original sources

Automated evaluation of single-cell reference atlas mappings enables the identification of disease-associated cell states

The rise of single-cell atlases has opened up the use of reference atlases as a comprehensive healthy control for the study of disease. A key step for using atlases is the mapping of "query" disease or perturbed datasets onto a healthy reference atlas, which allows for comparison of the query to healthy controls and thereby the identification of perturbation-specific transcriptional cell states. However, the mapping success, i.e. the extent to which these mappings correctly reflect biological similarities and differences between query and reference, varies with e.g. experimental confounders in the data (dissociation protocol, single-cell assay) or the mapping method used, and cannot be predicted in advance. Moreover, an unsuccessful mapping can result in falsely reporting technical artifacts as disease or perturbation-specific cellular changes and in overlooking true altered states. Here, we present MapQC, a method that quantifies query-to-reference mapping success by leveraging the information present in the reference embedding. Specifically, MapQC tests the presence of remaining batch effect in the embedding after mapping by comparing inter-sample distances in the healthy reference itself to distance of query control samples to the reference. Similarly, it tests whether disease or perturbation-specific variation has been retained during mapping by testing whether query perturbed samples are more distant to the reference than reference samples are from each other. We apply MapQC to lung and endometrial query datasets, including data of idiopathic pulmonary fibrosis and Asherman Syndrome, mapped to large-scale healthy references. We show that MapQC correctly distinguishes successful mappings from unsuccessful ones where data visualization techniques such as UMAP can be deceiving, and that mapQC outperforms integration metrics often re-purposed for mapping qualitycontrol. Moreover, only mappings that MapQC identified as successful result in the correct identification of cell state changes specific to disease. Taken together, MapQC provides a critical quality-control metric for a more reliable, robust, and accurate use of reference atlases to study disease.

bioinformatics↗

Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysis

Experimental mouse models are indispensable for the preclinical development of cancer immunotherapies, whereby complex interactions in the tumor microenvironment (TME) can be somewhat replicated. Despite the availability of diverse models, their predictive capacity for clinical outcomes remains largely unknown, posing a hurdle in the translation from preclinical to clinical success. This study systematically reviews and meta-analyzes clinical trials of chimeric antigen receptor (CAR-) T cell monotherapies with their corresponding preclinical studies. Adhering to PRISMA guidelines, a comprehensive search of PubMed and ClinicalTrials.gov was conducted, identifying 422 clinical trials and 3157 preclinical studies. From these, 105 clinical trials and 180 preclinical studies, accounting for 44 and 131 distinct CAR constructs, respectively, were included. Patient[s] responses varied based on the target antigen, expectedly with higher efficacy and toxicity rates in hematological cancers. Preclinical data analysis revealed homogenous and antigen-independent efficacy rates. Our analysis revealed that only 4 % (n = 12) of mouse studies used syngeneic models, highlighting their scarcity in research. Three logistic regression models were trained on CAR structures, tumor entities, and experimental settings to predict treatment outcomes. While the logistic regression model accurately predicted clinical outcomes based on clinical or preclinical features (Macro F1 and AUC > 0.8), it failed in predicting preclinical outcomes from preclinical features (Macro F1 < 0.5, AUC < 0.6), indicating that preclinical studies may be influenced by experimental factors not accounted for in the model. These findings underscore the need for better understanding the experimental factors enhancing the predictive accuracy of mouse models in preclinical settings.

cancer biology↗

TCR clustering by contrastive learning on antigen specificity.

Effective clustering of T-cell receptor (TCR) sequences could be used to predict their antigen-specificities. TCRs with highly dissimilar sequences can bind to the same antigen, thus making their clustering into a common antigen group a central challenge. Here, we develop TouCAN, a method that relies on contrastive learning and pre-trained protein language models to perform TCR sequence clustering and antigen-specificity predictions. Following training, TouCAN demonstrates the ability to cluster highly dissimilar TCRs into common antigen groups. Additionally, TouCAN demonstrates TCR clustering performance and antigen-specificity predictions comparable to other leading methods in the field.

bioinformatics↗